Tumor necrosis factor formulation

Details Tumor necrosis factor formulation Tumor necrosis factor formulation

A - Human Necessities

61

K

167/103.2

A61K 47/34 (2006.01) A61K 38/19 (2006.01) A61K 47/48 (2006.01)

Patent

CA 1283046

Abstract of the Disclosure A pharmaceutical composition is prepared utilizing biologically active, selectively conjugated TNF. The conjugation is of TNF to a water-soluble polymer selected from polyethylene glycol polymers or polyoxyethylated polyols, which polyethylene glycol polymer is unsubstituted or substituted at one end with an alkyl group and which polyol is unsubstituted.

533061

Affiliated with

Also associated with

Rating

Tumor necrosis factor formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor necrosis factor formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor necrosis factor formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1239119